Macrogenics (MGNX) Current Deferred Revenue (2012 - 2026)
Macrogenics' Current Deferred Revenue came in at $55.5 million for Q2 2026, up 605.1% from $7.87 million a year earlier but down 18.4% from the prior quarter.
Powered by 
Analysis
Macrogenics (MGNX) Current Deferred Revenue (2012 - 2026) Analysis & Trends
At the end of FY2025, Macrogenics' Current Deferred Revenue was $1.28 million, down 92.2% from FY2024.
- Current Deferred Revenue carries a five-year compound annual growth rate of -22.1% (FY2020 to FY2025).
- Going back by year, Current Deferred Revenue was $16.32 million in FY2024 (-24.6%), $21.65 million in FY2023 (+116.8%), $9.99 million in FY2022 (-51.6%) and $20.65 million in FY2021 (+363.3%).
- The five-year range for quarterly Current Deferred Revenue is $1.28 million (Q4 2025) to $67.99 million (Q1 2026).
- Year-over-year, Current Deferred Revenue increased in three of the last eight quarters, with growth averaging 86.8%.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q1 2022 (growth of 626.2%), and the weakest in Q4 2025 (a decline of 92.2%).
- Business Quant data shows MGNX's Current Deferred Revenue at $67.99 million (Q1 2026), $1.28 million (Q4 2025) and $10.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Macrogenics | 245.67 Mn | -72.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.50 Mn |
| Mar 31, 2026 | 67.99 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 10.30 Mn |
| Jun 30, 2025 | 7.87 Mn |
| Mar 31, 2025 | 15.62 Mn |
| Dec 31, 2024 | 16.32 Mn |
| Sep 30, 2024 | 23.31 Mn |
| Jun 30, 2024 | 23.82 Mn |
| Mar 31, 2024 | 22.84 Mn |
| Dec 31, 2023 | 21.65 Mn |
| Sep 30, 2023 | 18.58 Mn |
| Jun 30, 2023 | 9.67 Mn |
| Mar 31, 2023 | 9.25 Mn |
| Dec 31, 2022 | 9.99 Mn |
| Sep 30, 2022 | 7.09 Mn |
| Jun 30, 2022 | 11.57 Mn |
| Mar 31, 2022 | 25.56 Mn |
| Dec 31, 2021 | 20.65 Mn |
| Sep 30, 2021 | 16.31 Mn |
API Access
Macrogenics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "MGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();